Dr. Ravi Shankar P

Senior Consultant

28 Years of Experience

Radiation Oncologist

MBBS, MS, DNB

Reg. No.:66549, Tamil Nadu Medical Council

English

Consultation Fee ₹ 800

Book an Appointment Contact with Doctor

Expert Help When You Need It – Plan in 60 Minutes

Name*

Mobile Number*

Is the above number on WhatsApp? *

Yes

Query

Dr. Ravi Shankar P. is a surgical oncologist with over 28 years of experience in healthcare.
His areas of expertise are head & neck and gynecological malignancies.
Procedures like hyperthermic intraperitoneal chemotherapy (HIPEC) procedures, gastrointestinal malignancy surgeries, thyroid surgeries, and robotic surgeries are part of his skill set.
Dr. Ravi Shankar completed his MBBS at Karnataka University, Dharwad in 1995 and his MS in General Surgery at Rajiv Gandhi University of Health Sciences, Bengaluru in 2000.
In 2009, he obtained his DNB in Surgical Oncology at Apollo Hospitals, Chennai.
He is trained in surgical gastroenterology at the Asian Institute of Gastroenterology in Hyderabad.
Dr. Ravi Shankar is an avid researcher who has published articles in well-known journals such as the Journal of Gastrointestinal Cancer and Biomarkers in Cancer.

Expert Help When You Need It – Plan in 60 Minutes

Name*

Mobile Number*

Is the above number on WhatsApp? *

Yes

Query

MBBS, Karnataka University, Dharwad, 1995
MS (General Surgery), Rajiv Gandhi University of Health Sciences, Bengaluru, 2000
DNB (Surgical Oncology), Apollo Hospitals, Chennai, 2009

Training in Surgical Gastroenterology, Asian Institute of Gastroenterology, Hyderabad

Padmanabhan, N., Ahmed, S., Kurian, A., & Ravishankar, P. (2020). Unusual and Aggressive Cause of Gall Bladder Mass—Neuroendocrine Tumor. Journal of Gastrointestinal Cancer, 51(1), 307-310.
Thakkar, A. D., Raj, H., Chakrabarti, D., Ravishankar, Saravanan, N., Muthuvelan, B., ... & Padigaru, M. (2010). Identification of gene expression signature in estrogen receptor positive breast carcinoma. Biomarkers in Cancer, 2, BIC-S3793.
Thakkar, A., Raj, H., Ravishankar, Muthuvelan, B., Balakrishnan, A., & Padigaru, M. (2015). High expression of three-gene signature improves prediction of relapse-free survival in estrogen receptor-positive and node-positive breast tumors. Biomarker Insights, 10, BMI-S30559.